ArticleMedicine2026
Drug fever induced by Xingnaojing injection: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleThe application of Xingnaojing injection is widespread; however, drug-induced fever associated with this medication is challenging to diagnose. Previous literature rarely reports cases of drug-induced fever resulting from the use of Xingnaojing injection. PATIENT CONCERNS: A 46-year-old male patient, who underwent surgery for cerebral hemorrhage, presented with fever. The condition is considered to be drug fever induced by the administration of Xingnaojing. DIAGNOSES: Considering the potential for drug fever associated with the administration of Xingnaojing injection.
interventionsDiscontinue the use of Xingnaojing injection. OUTCOMES: The patient has shown improvement and is being discharged. LESSONS: Clinical practitioners should enhance the prevention and management of adverse drug reactions to reduce both patient hospitalization duration and economic costs, thereby ensuring the safety of medication use for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.